Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms
admin 23rd June 2017 Uncategorised 0The positive data for Roche’s Ocrevus keep on coming. Friday, the company’s Genentech unit announced that the multiple-sclerosis fighter had significantly cut down disease activity and disability progression in patients with relapsing forms of the disease and those with the harder-to-treat, primary progressive forms.
More: Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms
Source: fierce